{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:41:47Z","timestamp":1789508507233,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Large epidemiologic and clinical estimates of spondyloarthritis (SpA) in Latin America are not available. In this narrative review, our goal was to descriptively summarize the prevalence and features of SpA in Latin America, based on available small studies. A review of peer-reviewed literature identified 41 relevant publications. Of these, 11 (mostly based on Mexican data) estimated the prevalence of SpA and its subtypes, which varied from 0.28 to 0.9% (SpA), 0.02 to 0.8% (ankylosing spondylitis), 0.2 to 0.9% (axial SpA), and 0.004 to 0.08% (psoriatic arthritis). Demographic and\/or clinical characteristics were reported in 31 of the 41 publications, deriving data from 3 multinational studies, as well as individual studies from Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, Peru, Uruguay, and Venezuela. Data relating to treatment, disease manifestations (articular and extra-articular), and comorbidities were summarized across the countries. Available data suggest that there is a variability in prevalence, manifestations, and comorbidities of SpA across Latin America. Basic epidemiologic and clinical data are required from several countries not currently represented. Data relating to current treatment approaches, patient outcomes, and socioeconomic impact within this large geographic region are also needed.<\/jats:p>","DOI":"10.1186\/s42358-020-00161-5","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T10:03:28Z","timestamp":1610100208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis"],"prefix":"10.1186","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3724-1874","authenticated-orcid":false,"given":"Gustavo","family":"Citera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Bautista-Molano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingris","family":"Pel\u00e1ez-Ballestas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valderilio F.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto A.","family":"Perich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"M\u00e9ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel S.","family":"Cutri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia E.","family":"Borlenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"161_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit M, van der Heijde D, Landewe R, et al. The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70:25\u201331.","journal-title":"Ann Rheum Dis"},{"key":"161_CR2","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/acr.22831","volume":"68","author":"C Stolwijk","year":"2016","unstructured":"Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis. Arthritis Care Res. 2016;68:1320\u201331.","journal-title":"Arthritis Care Res"},{"key":"161_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2217\/ijr.10.12","volume":"5","author":"R Burgos-Vargas","year":"2010","unstructured":"Burgos-Vargas R, Pel\u00e1ez-Ballestas I, Guti\u00e9rrez-Su\u00e1rez R. Challenges in juvenile-onset spondyloarthritis. Int J Clin Rheumatol. 2010;5:229\u201339.","journal-title":"Int J Clin Rheumatol"},{"key":"161_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.rdc.2012.09.003","volume":"38","author":"C Stolwijk","year":"2012","unstructured":"Stolwijk C, Boonen A, van Tubergen A, Reveille JD. Epidemiology of spondyloarthritis. Rheum Dis Clin N Am. 2012;38:441\u201376.","journal-title":"Rheum Dis Clin N Am"},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1590\/S0482-50042010000500009","volume":"50","author":"AL Gallinaro","year":"2010","unstructured":"Gallinaro AL, Ventura C, Sampaio Barros PD, Goncalves CR. Spondyloarthritis: analysis of a Brazilian series compared with a large Ibero-American registry (RESPONDIA group). Rev Bras Reumatol. 2010;50:581\u20139.","journal-title":"Rev Bras Reumatol"},{"key":"161_CR6","first-page":"245","volume":"25","author":"J Londono","year":"2018","unstructured":"Londono J, Pelaez Ballestas I, Cuervo F, et al. Prevalence of rheumatic disease in Colombia acording to the Colombian Rheumatology Association (COPCORD) strategy. Prevalence study of rheumatic disease in Colombian population older than 18 years. Rev Colomb Reumatol. 2018;25:245\u201356.","journal-title":"Rev Colomb Reumatol"},{"key":"161_CR7","first-page":"S172","volume":"24","author":"DG Fern\u00e1ndez-\u00c1vila","year":"2018","unstructured":"Fern\u00e1ndez-\u00c1vila DG, Bernal-Mac\u00edas S, Rinc\u00f3n-Ria\u00f1o DN, Guti\u00e9rrez-D\u00e1vila JM, Rosselli-Cock D. Prevalence of rheumatic diseases in Colombia: an approach from the ministry of health and social protection data (SISPRO). J Clin Rheumatol. 2018;24:S172.","journal-title":"J Clin Rheumatol"},{"key":"161_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/RHU.0b013e31819b61cb","volume":"15","author":"GA Reyes-Llerena","year":"2009","unstructured":"Reyes-Llerena GA, Guibert-Toledano M, Penedo-Coello A, et al. Community-based study to estimate prevalence and burden of illness of rheumatic diseases in Cuba: a COPCORD study. J Clin Rheumatol. 2009;15:51\u20135.","journal-title":"J Clin Rheumatol"},{"key":"161_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3899\/jrheum.100951","volume":"86","author":"I Pel\u00e1ez-Ballestas","year":"2011","unstructured":"Pel\u00e1ez-Ballestas I, Sanin LH, Moreno-Montoya J, et al. Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl. 2011;86:3\u20138.","journal-title":"J Rheumatol Suppl"},{"key":"161_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3899\/jrheum.100952","volume":"86","author":"J Rodriguez-Amado","year":"2011","unstructured":"Rodriguez-Amado J, Pelaez-Ballestas I, Sanin LH, et al. Epidemiology of rheumatic diseases. A community-based study in urban and rural populations in the state of Nuevo Leon, Mexico. J Rheumatol Suppl. 2011;86:9\u201314.","journal-title":"J Rheumatol Suppl"},{"key":"161_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3899\/jrheum.100954","volume":"86","author":"J Alvarez-Nemegyei","year":"2011","unstructured":"Alvarez-Nemegyei J, Pelaez-Ballestas I, Sanin LH, Cardiel MH, Ramirez-Angulo A, Goycochea-Robles MV. Prevalence of musculoskeletal pain and rheumatic diseases in the southeastern region of Mexico. A COPCORD-based community survey. J Rheumatol Suppl. 2011;86:21\u20135.","journal-title":"J Rheumatol Suppl"},{"key":"161_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/RHU.0b013e3182862e65","volume":"19","author":"I Pel\u00e1ez-Ballestas","year":"2013","unstructured":"Pel\u00e1ez-Ballestas I, Navarro-Zarza JE, Julian B, et al. A community-based study on the prevalence of spondyloarthritis and inflammatory back pain in Mexicans. J Clin Rheumatol. 2013;19:57\u201361.","journal-title":"J Clin Rheumatol"},{"issue":"Suppl 1","key":"161_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10067-016-3225-x","volume":"35","author":"ND Del Rio","year":"2016","unstructured":"Del Rio ND, Santana N, Pelaez-Ballestas I, Gonzalez-Chavez SA, Quinonez-Flores CM, Pacheco-Tena C. Prevalence of rheumatic diseases in Raramuri people in Chihuahua, Mexico: a community-based study. Clin Rheumatol. 2016;35(Suppl 1):43\u201352.","journal-title":"Clin Rheumatol"},{"issue":"Suppl 1","key":"161_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10067-015-3148-y","volume":"35","author":"F Julian-Santiago","year":"2016","unstructured":"Julian-Santiago F, Garcia-Garcia C, Garcia-Olivera I, Goycochea-Robles MV, Pelaez-Ballestas I. Epidemiology of rheumatic diseases in Mixtec and Chontal indigenous communities in Mexico: a cross-sectional community-based study. Clin Rheumatol. 2016;35(Suppl 1):35\u201342.","journal-title":"Clin Rheumatol"},{"key":"161_CR15","first-page":"1652","volume":"60","author":"I Pel\u00e1ez-Ballestas","year":"2009","unstructured":"Pel\u00e1ez-Ballestas I, Navarro-Zarza E, Julian B, et al. The prevalence of inflammatory back pain, spondyloarthritis, and axial spondyloarthritis in the community. Arthritis Rheum. 2009;60:1652\u20133.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"161_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10067-016-3194-0","volume":"35","author":"Y Granados","year":"2016","unstructured":"Granados Y, Rosillo C, Cedeno L, et al. Prevalence of musculoskeletal disorders and rheumatic disease in the Warao, Kari'na, and Chaima indigenous populations of Monagas State, Venezuela. Clin Rheumatol. 2016;35(Suppl 1):53\u201361.","journal-title":"Clin Rheumatol"},{"key":"161_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/RHU.0b013e31817d1089","volume":"14","author":"MF Marengo","year":"2008","unstructured":"Marengo MF, Schneeberger EE, Citera G, Cocco JA. Work status among patients with ankylosing spondylitis in Argentina. J Clin Rheumatol. 2008;14:273\u20137.","journal-title":"J Clin Rheumatol"},{"key":"161_CR18","first-page":"S23","volume":"4","author":"V Bellomio","year":"2008","unstructured":"Bellomio V, Berman A, Sueldo RR, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Argentina. Reumatol Clin. 2008;4:S23\u20139.","journal-title":"Reumatol Clin"},{"key":"161_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/MAJ.0b013e31820f8cc3","volume":"341","author":"E Buschiazzo","year":"2011","unstructured":"Buschiazzo E, Maldonado-Cocco JA, Arturi P, et al. Epidemiology of spondyloarthritis in Argentina. Am J Med Sci. 2011;341:289\u201392.","journal-title":"Am J Med Sci"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/rheumatology\/keq369","volume":"50","author":"ER Soriano","year":"2011","unstructured":"Soriano ER, Rosa J, Velozo E, et al. Incidence and prevalence of psoriatic arthritis in Buenos Aires, Argentina: a 6-year health management organization-based study. Rheumatology (Oxford). 2011;50:729\u201334.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s10067-014-2739-3","volume":"34","author":"EE Schneeberger","year":"2015","unstructured":"Schneeberger EE, Citera G, Rodriguez Gil G, et al. Clinical and immunogenetic characterization in psoriatic arthritis patients. Clin Rheumatol. 2015;34:1413\u20138.","journal-title":"Clin Rheumatol"},{"key":"161_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5152\/eurjrheum.2018.18002","volume":"5","author":"F Sommerfleck","year":"2018","unstructured":"Sommerfleck F, Schneeberger E, Citera G. Comorbidities in Argentine patients with axial spondyloarthritis: Is nephrolithiasis associated with this disease? Eur J Rheumatol. 2018;5:169\u201372.","journal-title":"Eur J Rheumatol"},{"key":"161_CR23","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00296-018-4148-4","volume":"38","author":"FA Sommerfleck","year":"2018","unstructured":"Sommerfleck FA, Schneeberger EE, Orozco MC, Zamora N, Landi M, Citera G. Validation and cultural adaptation of the qualisex questionnaire in patients with axial spondyloarthritis in Argentina. Rheumatol Int. 2018;38:2103\u20139.","journal-title":"Rheumatol Int"},{"key":"161_CR24","first-page":"139","volume":"22","author":"S Scarafia","year":"2016","unstructured":"Scarafia S, Duarte V, Romanini FE, et al. Prevalence of overweight and obesity in early psoriatic arthritis clinic. J Clin Rheumatol. 2016;22:139.","journal-title":"J Clin Rheumatol"},{"key":"161_CR25","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/RHU.0000000000000637","volume":"24","author":"D Capelusnik","year":"2018","unstructured":"Capelusnik D, Cavalieri M, Rol\u00f3n Campuzano R, et al. Prevalence and characteristics of uveitis in a large cohort of patients with axial spondyloarthritis. J Clin Rheumatol. 2018;24:S103\u20134.","journal-title":"J Clin Rheumatol"},{"key":"161_CR26","first-page":"S30","volume":"4","author":"PD Sampaio-Barros","year":"2008","unstructured":"Sampaio-Barros PD, Gon\u00e7alves CR, Braga da Silva JA, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Brasil. Informe del Registro Brasile\u00f1o de Espondiloartritis. Reumatol Clin. 2008;4:S30\u20135.","journal-title":"Reumatol Clin"},{"key":"161_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3899\/jrheum.110372","volume":"39","author":"TL Skare","year":"2012","unstructured":"Skare TL, Bortoluzzo AB, Goncalves CR, et al. Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. J Rheumatol. 2012;39:141\u20137.","journal-title":"J Rheumatol"},{"key":"161_CR28","first-page":"351","volume":"30","author":"TL Skare","year":"2012","unstructured":"Skare TL, Leite N, Bortoluzzo AB, et al. Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients. Clin Exp Rheumatol. 2012;30:351\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"161_CR29","first-page":"375","volume":"52","author":"CE Rodrigues","year":"2012","unstructured":"Rodrigues CE, Vieira WP, Bortoluzzo AB, et al. Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis. Rev Bras Reumatol. 2012;52:375\u201383.","journal-title":"Rev Bras Reumatol"},{"key":"161_CR30","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.rbr.2014.06.005","volume":"54","author":"AP Duarte","year":"2014","unstructured":"Duarte AP, Marques CD, Bortoluzzo AB, et al. Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort. Rev Bras Reumatol. 2014;54:424\u201330.","journal-title":"Rev Bras Reumatol"},{"key":"161_CR31","first-page":"195","volume":"383","author":"SLE Ribeiro","year":"2018","unstructured":"Ribeiro SLE, de Campos APB, Palominos PE, et al. Different ethnic background is associated with distinct clinical profiles in the spondyloarthritides in the North and South of Brazil. Clin Rheumatol. 2018;383:195\u2013203.","journal-title":"Clin Rheumatol"},{"key":"161_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.arcmed.2019.04.003","volume":"50","author":"J Simioni","year":"2019","unstructured":"Simioni J, Skare TL, Campos APB, et al. Fecal calprotectin, gut inflammation and spondyloarthritis. Arch Med Res. 2019;50:41\u20136.","journal-title":"Arch Med Res"},{"key":"161_CR33","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/RHU.0000000000000635","volume":"24","author":"L Henrique","year":"2018","unstructured":"Henrique L, Mello A, Kohem C, et al. Psoriatic arthritis patients followed in university hospitals in southern Brazil have a high prevalence of metabolic syndrome, overweight\/obesity, diabetes and hypertension. J Clin Rheumatol. 2018;24:S106.","journal-title":"J Clin Rheumatol"},{"key":"161_CR34","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S1699-258X(08)76167-9","volume":"4","author":"MA Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez MA, P\u00e9rez C, Saavedra J, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Chile. Reumatol Clin. 2008;4:S41\u20137.","journal-title":"Reumatol Clin"},{"key":"161_CR35","first-page":"A477","volume":"78","author":"S Ibanez","year":"2019","unstructured":"Ibanez S, van Bentum R, Valenzuela O, van der Horst-Bruisnsma I. Chilean axial spondyloarthritis patients report high disease burden and impaired work activity - an internet survey in 472 patients. Ann Rheum Dis. 2019;78:A477.","journal-title":"Ann Rheum Dis"},{"key":"161_CR36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MAJ.0b013e31820f8cdb","volume":"341","author":"R Valle-Onate","year":"2011","unstructured":"Valle-Onate R, Candia L, Romero-Sanchez C, et al. Epidemiology of spondyloarthritis in Colombia. Am J Med Sci. 2011;341:293\u20134.","journal-title":"Am J Med Sci"},{"key":"161_CR37","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s10067-016-3184-2","volume":"35","author":"W Bautista-Molano","year":"2016","unstructured":"Bautista-Molano W, Landewe RB, Londono J, Romero-Sanchez C, Valle-Onate R, van der Heijde D. Analysis and performance of various classification criteria sets in a Colombian cohort of patients with spondyloarthritis. Clin Rheumatol. 2016;35:1759\u201367.","journal-title":"Clin Rheumatol"},{"key":"161_CR38","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10067-016-3516-2","volume":"36","author":"AM Santos","year":"2017","unstructured":"Santos AM, Pena P, Avila M, et al. Association of human leukocyte A, B, and DR antigens in Colombian patients with diagnosis of spondyloarthritis. Clin Rheumatol. 2017;36:953\u20138.","journal-title":"Clin Rheumatol"},{"key":"161_CR39","first-page":"S36","volume":"4","author":"CR S\u00e1enz","year":"2008","unstructured":"S\u00e1enz CR. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Costa Rica. Reumatol Clin. 2008;4:S36\u201340.","journal-title":"Reumatol Clin"},{"key":"161_CR40","first-page":"S56","volume":"4","author":"JC Casasola-Vargas","year":"2008","unstructured":"Casasola-Vargas JC, Flores-Alvarado DE, Huerta-Sil G, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): M\u00e9xico. Reumatol Clin. 2008;4:S56\u201362.","journal-title":"Reumatol Clin"},{"key":"161_CR41","first-page":"S63","volume":"4","author":"JE Ch\u00e1vez-Corrales","year":"2008","unstructured":"Ch\u00e1vez-Corrales JE, Montero J\u00e1uregui M, Alva Linares M, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Per\u00fa. Reumatol Clin. 2008;4:S63\u20137.","journal-title":"Reumatol Clin"},{"key":"161_CR42","first-page":"S73","volume":"4","author":"DR Palleiro","year":"2008","unstructured":"Palleiro DR, Spangenberg E. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Uruguay. Reumatol Clin. 2008;4:S73\u20138.","journal-title":"Reumatol Clin"},{"key":"161_CR43","first-page":"S79","volume":"4","author":"R Chac\u00f3n","year":"2008","unstructured":"Chac\u00f3n R, Granados Y, Esteva MH, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Venezuela. Reumatol Clin. 2008;4:S79\u201386.","journal-title":"Reumatol Clin"},{"key":"161_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/MAJ.0b013e31820f8cf1","volume":"341","author":"A Garc\u00eda-Kutzbach","year":"2011","unstructured":"Garc\u00eda-Kutzbach A, Montenegro A, Iraheta I, Bara C, Saenz R. Epidemiology of spondyloarthropathies in Central America. Am J Med Sci. 2011;341:295\u20137.","journal-title":"Am J Med Sci"},{"key":"161_CR45","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.3899\/jrheum.110687","volume":"39","author":"M Benegas","year":"2012","unstructured":"Benegas M, Munoz-Gomariz E, Font P, et al. Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America. J Rheumatol. 2012;39:2315\u201320.","journal-title":"J Rheumatol"},{"key":"161_CR46","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3899\/jrheum.170520","volume":"45","author":"W Bautista-Molano","year":"2018","unstructured":"Bautista-Molano W, Landew\u00e9 R, Burgos-Vargas R, et al. Prevalence of comorbidities and risk factors for comorbidities in patients with spondyloarthritis in Latin America: a comparative study with the general population and data from the ASAS-COMOSPA study. J Rheumatol. 2018;45:206\u201312.","journal-title":"J Rheumatol"},{"key":"161_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/rheumatology\/ket387","volume":"53","author":"LE Dean","year":"2014","unstructured":"Dean LE, Jones GT, MacDonald AG, Downham C, Sturrock RD, Macfarlane GJ. Global prevalence of ankylosing spondylitis. Rheumatology (Oxford). 2014;53:650\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"161_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00002281-199507000-00001","volume":"7","author":"MA Khan","year":"1995","unstructured":"Khan MA. HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol. 1995;7:263\u20139.","journal-title":"Curr Opin Rheumatol"},{"key":"161_CR49","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","volume":"75","author":"A Molto","year":"2016","unstructured":"Molto A, Etcheto A, van der Heijde D, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis. 2016;75:1016\u201323.","journal-title":"Ann Rheum Dis"},{"key":"161_CR50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fmed.2018.00062","volume":"5","author":"A Molto","year":"2018","unstructured":"Molto A, Nikiphorou E. Comorbidities in spondyloarthritis. Front Med (Lausanne). 2018;5:62.","journal-title":"Front Med (Lausanne)"},{"key":"161_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/RHU.0000000000000881","volume":"25","author":"VF Azevedo","year":"2019","unstructured":"Azevedo VF, Babini A, Caballero-Uribe CV, Castaneda-Hernandez G, Borlenghi C, Jones HE. Practical guidance on biosimilars, with a focus on Latin America: what do rheumatologists need to know? J Clin Rheumatol. 2019;25:91\u2013100.","journal-title":"J Clin Rheumatol"},{"key":"161_CR52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/MAJ.0b013e3181e8bcb0","volume":"340","author":"I Contreras-Yanez","year":"2010","unstructured":"Contreras-Yanez I, Ponce De Leon S, Cabiedes J, Rull-Gabayet M, Pascual-Ramos V. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying antirheumatic drugs. Am J Med Sci. 2010;340:282\u201390.","journal-title":"Am J Med Sci"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-020-00161-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-020-00161-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-020-00161-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T22:06:16Z","timestamp":1674857176000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-020-00161-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1186\/s42358-020-00161-5","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GC received speaker fees from AbbVie, Pfizer, BMS, Roche, Lilly, and Novartis; WBM received speaker fees from Novartis, Janssen, and Pfizer; VA received speaker fees from AbbVie, Pfizer, Janssen, Novartis, Sanofi, and Sandoz and received grants for clinical trials from GSK, Lilly, Pfizer, Genentech, Boehringher Ingelheim, and AbbVie. MC and CB are employees of Pfizer. RAP, IPB, and JAMR did not declare any conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}